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The equilibrium problems, characterized by recurring end-points,
involved in the reaction of iron (III) with iodide make the batch
iodometric determination of iron (III) unsuitable. Since theflow
injection delermination does not require attainment of steady state
either for mixing of reagents or for the chemical reaction, the
iodometric determination has been accurately and precisely per-
formed using this technique in the present work. This method does
not require any special reagent, including chelating agents or those
which are loxic, and has a limit of detection of 0.2 #tool
(11 #g 1-1) of iron (Ill). The interference offluoride has been
avoided by adding zirconyl nitrate to the test sample solution, and
ofcopper (II) by complexformation with 2-mercaptobenzoxazole.
The method has been applied to determine iron (III) in natural
waters, and total iron in drugs.
Introduction
Iron is an essential trace element involved in normal
growth and development. The importance of iron in
nutrition has been recognized and, therefore, this element
is often added in certain foodstuffs. Reliable speciation of
iron (II) and iron (Ill) is fundamental for the proper
characterization of many of the processes in terrestrial
and aquatic environments [1], and is also of practical
importance in the investigation of corrosion of iron and
the treatment of wastewaters from the mining and steel
industries [2]. The determination of the oxidation state of
iron in a variety of natural water samples has generally
been performed by complexation with specific chelating
agents ibllowed by spectrophotometry [3-8] or voltam-
merry [9-11]. To attain adequate sensitivity of the
method in dealing with the analysis of iron at gmoll
or lower levels, pre-concentration procedures have been
reported using the natural polymer Chitin [12], Chelex
100 [13], melamine-formaldehyde resin [14], or by solid
phase extraction on Cla cartridge 15,16].
When a chelating agent is developed for determination,
one has to be aware of the strength of the iron-chelator
complex. This is important in order to assess the useful-
ness of the chelator with respect to naturally occurring
chelators in the ambient water samples. If naturally
occurring ligands have large stability constants, e.g.
EDTA-iron (III) (/3= 1025), then the concentrations
obtained with chelating methods are only erroneous
[8]. Another aspect deals with the potential changes in
the oxidation state of iron in the sample due to the
changes in the redox potential between iron (II)/iron
(III) oxidation states. This change in redox potential is
due to the favourable stabilization of one oxidation state
over the other when a chelating agent is added to the
natural water samples. This is an important aspect in
measuring a specific redox state of iron at low ambient
levels. Thus, techniques which eliminate the need for
using chelating agents are worth re-evaluation.
In the present work, a flow injection spectrophotometric
method is described which does not make use ofchelating
agent or toxic reagents, but is sensitive to gmol -
levels
of iron (III).
Experimental
Inslrumenlalion
Shimadzu LC-5A reciprocating pump (Tokyo) and
Ismatec Mini-S 820 peristaltic pump (Zurich) were used
tbr propelling the carrier stream of water and reagents,
respectively. Rheodyne 5020 low pressure PTFE 4-way
valve (Anachem, Luton) was used for injection ofsample
solution. Shimadzu SPD-2A variable wavelength detec-
tor (8t,tl flow-through cell) and Shimadzu C-R2AX
integrator fitted with a printer was used for measurement
of peak height. PTFE tubings (Anachem), 0.5mm i.d.,
were used for construction of flow lines. All flanged
connections were made with plastic nuts and TEFZEL
coupler. Home-made T-joints of 0.8mm i.d. were em-
ployed.
The flow-injection manifold used for the analysis of iron
(Ill) is given in figure 1. It consisted of three channels,
the first two, mounted on a peristaltic pump, were used
for propelling potassium iodide and hydrochloric acid
streams. Both iodide and acid were mixed in a delay coil
and downstream merged with the third channel used for
the water carrier stream. The four-way loop injection
valve was mounted on the water carrier stream. Another
delay coil was used for the reaction to occur before
detection at 360 nm.
Reagents and standards
Hydrochloric acid, 0.25 mol -
was used as the carrier in
the optimized method.
A stock 0.01 moll
-1 iron (III) solution was prepared as
follows. Iron (II) ammonium sulphate, 3.92g, was dis-
solved in about 100ml of water, mixed dropwise while
stirring with 5 ml of concentrated nitric acid, boiled for
5 min, and then cooled to 50-60C. About 3 g of potas-
siren peroxodisulphate was added portionwise with stir-
ring. The solution was diluted to about 200 ml and again
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Figure 1. Schematic diagram of theflow injection manifold used
for the determination of iron(Ill). Potassium iodide, 8%, and
0.25M hydrochloricid acid were used as reagents, and deinized
distilled water as carrier. P1--peristalticpump; P2--HPLC
reciprocating pump; INJ= injection valve (lO0-#l loop);
L1 50 cm mixing coil; L2-- 20 cm reaction coil,
D detector set at 360 nm; INT-PR integrator and printer;
W waste. Allflow lines were made from 0.5mm i.d. PTFE
tubing.
boiled for about 10 min. The cooled solution was treated
with ammonia (1:1, concentrated ammonia-water) till
slight precipitation of iron (III) hydroxide. The precipi-
tate was redissolved by adding 0.25 mol 1-1 hydrochloric
acid, and the solution made up to in a standard flask
with the same solvent.
For standardization of iron (III) solution [17,18], a 5 ml
aliquot of iron (III) solution was treated either with 5 ml
of 0.01moll
-] ascorbic acid or 10ml of 0.01moll
--I
mercaptoacetic acid and swirled for min. About 0.1 g
of potassium iodide and ml of 1% starch were added,
and the residual amount of ascorbic acid or mercaptoa-
cetic acid from the reaction was evaluated by back
titration with 0.01 moll
-1 chloramine T, a blue colour
was obtained at the end-point. Iron (III) reacts with
ascorbic acid or mercaptoacetic acid in a molar ratio of
2:1 and 1:1, respectively. The strength of iron (III)
solution determined by two methods agreed within 1%.
The stock solution was sequentially diluted with
0.25moll
-l hydrochloric acid to give test solutions of
iron (III).
All other substances used were of high purity, and their
solutions were made by dissolving the right amounts in
water.
Procedures
Wet ashing of iron tablets. A known number of tablets or
contents of capsules were weighed and finely ground. A
weight equivalent to a tablet or contents of a capsule was
transferred to a 100 ml Kjeldahl flask, mixed with about
20ml of water and boiled over a small flame till the
volume was reduced to about 5ml. The solution was
cooled to room temperature and carefully mixed with
15 ml of concentrated nitric acid and then with 10 ml of
concentrated sulphuric acid. The flask was kept at room
temperature for about 15 min then heated slowly to boil
the contents under a fume-cupboard where copious fumes
of nitrogen oxides evolved. The above process was re-
peated twice by adding both acids, and heating till no
more brown fumes evolved. About 50 ml of water along
with 5 g of potassium peroxodisulphate was added, and
boiling continued till the contents of the flask evaporated
to almost dry. The dried matter was boiled with 25 ml of
water, and transferred quantitatively to a 250 ml beaker,
filtering any insoluble matter. The clear filtrate was
treated with 1" ammonia-water till slight precipitation
of iron (III) hydroxide, the precipitate was redissolved
by adding 0.25mol1-1 hydrochloric acid, and finally
diluted to 250ml in a standard flask with the same
solvent.
Removal of copper (II). 2-Mercaptobenzoxazole was im-
pregnated on silica gel using the procedure as reported
for impregnation of 2-mercaptobenzothiazole [19]. The
column was filled with impregnated silica gel to give a
bed height of about cm which was secured in position
by placing one Whatman filter No. 42 disc above and
another below the bed. A known volume ofdrug solution
prepared as above was passed through the column under
mild suction (1-2mlmin-1). The column was washed
with about 2ml of water. The combined eluent and
washings were boiled with 2ml of concentrated nitric
acid, cooled and diluted to a known volume.
Results and discussion
Though iodimetric titration of iron (III), which involves
the reaction of iron (III) with acidified iodide and
titration of the liberated iodine with standard thiosul-
phate, has been recommended in British Pharmacopoeia,
1968, the most frequent [20] difficulties are encountered
due to recurring end-points, as the reaction is very slow
near the stoichiometric end-point. Extraction of the
liberated iodine into chloroform or carbon tetrachloride
has been recommended to push the reaction to com-
pletion [20]. However, such titrations involving two
immiscible phases are always cumbersome and the end-
point is often carried over.
Flow injection analysis does not require the attainment of
a steady state for mixing of reactants or for the chemical
reaction, and the signals, though transient, are highly
reproducible. This unique feature of the flow injection
technique was tested for the analysis of iron (III) by its
reaction with iodide, and the conditions have been
optimized for achieving maximum sensitivity.
Study offlow injection variables
The flow injection manifold, as given in figure 1, was
used when the acid and potassium iodide reagents
streams were each maintained at 0.2mlminq, carrier
flow rate was ml min-], loop size was 75 gl, mixing coil
and reaction coil were, respectively, 50 and 25 cm. The
effect of all the variables was evaluated. There was an
optimum peak height observed when 0.25 moll
-1 hydro-
chloric acid was used. The peak height increased when
up to 8% potassium iodide was used, then remained
practically constant at higher concentration. In the
optimized procedure, an 8% potassium iodide was
used. Optimum flow rates were: carrier stream
mlmin-, acid stream 0.2mlmin-
and potassium io-
dide stream 0.4 ml rain-.
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A 50cm coil was necessary for complete mixing of
potassium iodide and hydrochloric acid mixed reagents
streams. A 20 cm reaction coil was found to give optimum
peak height. The signal was optimum when a 1001al
sample was introduced into the flow system.
to be .0.2gmoll-
(11gg -) iron (III) [S/N 3;
RSD 3.5%] which compares favourably with that of
diverse procedures for iron determination (table 2), and
is an important feature of this method since no special
reagent is necessary.
Validation of the analytical procedures
The flow injection analysis of iron (III) was validated by
injecting known amounts ofstandards in the flow system.
Calibration graphs were constructed on two concentra-
tion ranges of 0.01-0.1 mmol --
and 1-10 gmol 1-7 iron
(III). The analytical characteristics of calibration graphs
are given in table 1. The limit ofdetection has been found
Masking offluoride in natural waters
Fluoride forms a stable complex with iron (III), hexa-
fluoroferrat (III), which does not liberate iodine on
reaction with iodide. Thus, the interference of fluoride
was avoided by adding zirconyl nitrate to the test sample
solution when a still more stable complex zirconyl fluor-
ide is formed leaving iron (III) free.
Table 1. Analytical characteristics of the flow injection spectrophotometric determination of iron
(III); the absorbance was recorded at 360nm with AFS 0.32. Six calibration points offive
replicates each were sampled.
Range Slope* Intercept* r
0.01-0.1 mmol 1-1 12 938.3 IU.1 mmol--I
1-10 lamol 1-1 11.92 IU.1 ILtmol-
*IU integrator arbitrary units.
37.31 IU 0.9996
5.29 IU 0.9992
Table 2. Comparison of diverse methodsfor iron determination (without preconcentration).
Technique Reagent Limit of detection, Imol 1-1
Spectrophotometry Iodide 0.2
1,10-Phenanthroline 0.36
1,10-Phenanthroline 0.2
Ferrozine 0.1
Ferrozine 0.2
-Amino-4-hydroxyanthraquinone 20
Spectrofluorimetry 5-(4-methylphenylazo)-8-Aminoquinoline 0.18
Potentiometry Solochrome Violet RS 0.25
1,10-Phenanthroline 0.54
Flame AAS 0.2
This work
3,5
15
8
22
23
24
25
26
Table 3. Determination of iron (III) and total iron in the presence of copper (II) involving sorption of
copper (II) with 2-mercaptobenzoxazole.
% Found after extraction of copper (II)
Iron (III) Copper (II) %RSD %RSD
#moll
-1 taken #mol 1-1 h’on (III) (n 5) Total iron (n 5)
5 2 96.1 1.8 99.9
5 97.2
10 98.4 2.9 100.1 2.1
10 2 98.7
10 97.1
20 98.5 2.2 99.6 2.9
20 2 96.2
20 98.2 99.2
40 98.8 2.5 100.5 2.2
40 2 95.8 2.3
40 97.0 2.8 98.9
80 98.2 101.2 2.8
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Removal of copper (II)from drugformulations
Sorption of copper (II) by complexation with thiol
reagents loaded on to silica gel has been documented
[19]. Since all general thiols also reduce iron (III),
attempts were made to complex copper (II) without
significant reduction of iron (III). Reagents which were
tried include 2-mercaptobenzothiazole, -benzimidazole
and-benzoxazole, and triphenylmethanethiol. Triphe-
nylmethanethiol showed minimal reduction of iron (less
than 1%) but was too sluggish in the sorption of copper
(II). 2-Mercaptobenzoxazole was found to be the best
reagent among those tested. Results are given in table 3
for the determination of iron (III) and total iron in the
presence of copper. There was a 4-5% reduction of iron
(III) on the sorbent, however, this was less appreciable
when the copper (II)/iron (III) ratio was more than 1,
ostensibly due to greater reactivity of the sorbent towards
copper (II). Any iron (II) formed during sorption was
reoxidized before analysis of total iron in drugs.
samples were filtered through a 0.45 gm membrane filter,
the filtrate was acidified with 0.5ml of concentrated
hydrochloric acid per 500ml of sample, treated with
1% (w/v) zirconyl nitrate to mask fluoride, if also pres-
ent, and analysed. The method was further validated by
standard addition method. The results obtained for the
addition of known amounts of iron (III) to natural
samples gave an average recovery of 102% with a
standard deviation of 5.4% (table 4). The concentration
of copper (II) in natural waters is usually low enough so
as not to interfere in the determination or iron (III) [21].
Application of the method to the determination of total iron in drugs
The present method has been applied to determine total
iron in certain pharmaceutical preparations. The results
obtained have been compared with those found by a
previously checked procedure [18] (table 5). The present
method has been found to be rapid and precise.
Application of the method to natural waters Interferences
The present flow injection method was applied to deter-
mine iron (III) present in certain natural waters. The
Chelating methods are usually severely interfered by
fluoride, EDTA and phosphate. Many of these agents
Table 4. Flow injection spectrophotometric determination of iron (III) in natural waters.
h’on (III) added Iron (III) flound Recovery
Water sample #mol l-1 #mol l- (% ) *
%RSD
(n =)
Well water
Tap water No.
Tap water No. 2
Ground water No.
Ground water No. 2
Ground water No. 3
0
10.0
0
5.0
0
5.0
0
10.0
0
5
0
50.0
* The results are the average of six determinations.
15.0
26.4 114
2.32
7.20 98
3.89
9.00 102
4.05
13.87 98
3.75
8.55 96
70.4
125.0 109
4.5
5.0
6.1
5.9
7.1
5.6
5.9
5.3
7.0
6.5
4.3
4.6
Table 5. Results of theflow injection spectrophotometric determination of total iron in drugs.
Total iron, mg, per tablet or capsule
Found by Found by
Label present comparison
Drug claimed method* % RSD method [18]’
Fesovit capsule 54.0 48.4 5.6 50.0
Autrin capsule 113.9 109.3 6.2 105.0
Haematinic tablet 25.0 21.2 5.8 20.4
* The results are the average of five determinations.
]" The results are the average of three determinations.
Also contains ascorbic acid (50 mg), thiamine mononitrate (2 mg), nicotinamide (15 mg),
pyridoxine hydrochloride (1 mg), pantothenic acid (calcium salt) (2.5 mg) and amaranth.
Also contains ascorbic acid (150 mg), cyanocobalamine (15 lag) and folic acid (1.5 mg).
Also contains ascorbic acid (35 mg), calcium citrate (500 mg), vitamin B2 (2 mg), vitamin B6
(1 mg), folic acid (0.3 rag) and vitamin E (1 lag). Each tablet was mixed with 5 mg of copper (II).
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either do not interfere in the iodide method or can be
masked with suitable reagents.
Chlorine and chlorine dioxide are other oxidizing agents
that may be present in drinking water along with iron
(III). Their interference can be removed by purging with
nitrogen (for chlorine dioxide) or treatment with sodium
oxalate (for chlorine) before analysis for iron (III).
Nitrite can be decomposed with ammonium chloride in
feebly acidic medium.
Conclusions
The sensitivity of the present method involving oxidation
of iodide is comparable to those which use chelating
agents, e.g. 1,10-phenanthroline or ferrozine, or based
on AAS. Flow injection circumvents the equilibrium
problems of the reaction which are commonly observed
in batch methods.
The present method does not make use of any special
reagent. It is simple and rapid, and suitable for sensitive
determination ofiron (III) in environmental waters, and
total iron in drugs. The method has potential for its
application to other samples, e.g. foodstuffs.
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